50.5% achieved 15% or more STEP 2 (1,210 adults with T2D): 9.6% mean weight loss STEP 3 (with behavioral therapy): 16.0% mean weight loss STEP 5 (2-year data): 15.2% sustained weight loss at 104 weeks Zovaglutide (Phase 2)# Zovaglutide Phase 2 results (presented at EASD 2025) enrolled 303 overweight or obese adults across five dose arms over 24 weeks: Cross-Trial Comparison (Important Caveats)# Zovaglutide's Phase 2 results (10.6-14.4% at 24 weeks) suggest a competitive weight loss trajectory, but several critical differences preclude direct comparison: Duration : 24 weeks (zovaglutide) vs 68 weeks (semaglutide STEP 1)
Sticking to consistent tracking habits, especially at critical points like the 12-week milestone, gives you and your provider the insight to make thoughtful adjustments
While the long-term health impacts of using the sprays were not yet known, studies had shown a potential link to melanoma, a type of skin cancer, the CTSI warned
This means you can send a message to your care team and receive a response within a specified timeframe, rather than needing to schedule a real-time appointment for every question
While some ROS generation, produced via NADPH-dependent NOX and iNOS, is advantageous and necessary for pathogen clearance, it must be carefully titrated by antioxidant GSH which is itself regulated by NADPH-dependent glutathione reductase
Brunton LL et al (Eds.), McGraw Hill